Milan

• A Phase 2, Open-Label, Multicenter, Cohort Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab in Patien … Ended
  2024-513229-22-00 4 2022-04-21 Advanced cutaneous melanoma and Advanced mucosal melanoma
• Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ended
  2023-504825-38-00 4 2022-04-15 Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN)
• A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended
  2024-514372-40-00 5 2022-04-12 Anterior ST-Elevation Myocardial Infarction
• A study to evaluate Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality Ended
  2023-509140-10-00 5 2022-04-05 Pulmonary Arterial Hypertension (PAH)
• A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patient … Ended
  2024-514130-20-00 5 2022-04-04 complement 3 glomerulopathy (C3G)/immune complex membranoproliferativ
• A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study Ended
  2024-511560-93-00 5 2022-03-29 Schizophrenia
• ​​Sotorasib and Panitumumab Versus Investigator’s Choice for Subjects with KRAS p.G12C Mutation (CodeBreaK 300)​ Ended
  2024-511187-81-00 5 2022-03-28 Colorectal Cancer (CRC)
• A study to evaluate efficacy, safety and tolerability, pharmacokinetics and pharmacodynamics of emapalumab in children and adults with macro … Ended
  2024-516153-52-00 10 2022-03-28 Macrophage activation syndrome (MAS) in the context of Systemic Juveni
• Brightline-1: A study to compare brigimadlin (BI 907828) with doxorubicin in people with a type of cancer called dedifferentiated liposarcom … Ended
  2024-511361-11-00 10 2022-03-25 Advanced dedifferentiated liposarcoma
• An open label, single-arm, phase 2 study of neoadjuvant sacituzumab govitecan, before radical cystectomy, for patients with muscle-invasive … Ended
  2024-515301-26-00 4 2022-03-23 Muscle-invasive bladder cancer
• Long-term Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder Ended
  2024-512108-20-00 5 2022-03-16 Obsessive Compulsive Disorder
• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections … Ended
  2023-510088-37-00 5 2022-03-15 Acyclovir-resistant mucocutaneous HSV infections in immunocompromised
• A study to learn if brivaracetam works and is safe in children and young adults 2 to 25 years of age with childhood absence epilepsy or juve … Ended
  2023-510428-55-00 10 2022-03-10 Childhood Absence Epilepsy Juvenile Absence Epilepsy
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia. Ended
  2024-510696-38-00 5 2022-03-08 Severe Hypertriglyceridemia.
• Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended
  2023-503572-24-00 5 2022-03-02 Chronic Obstructive Pulmonary Disease (COPD)
• Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Colitis Ended
  2023-506004-93-00 4 2022-03-01 Ulcerative Colitis (UC)
• A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease Ended
  2024-512756-38-00 4 2022-02-17 Crohn`s Disease (CD)
• GliflOzin in eLderly Diabetic patiENts: A praGmatic intraclass Evaluation trial Ended
  2024-518915-20-00 6 2022-02-16 Type 2 diabetes mellitus
• A study to evaluate the efficacy and safety of olorofim versus AmBisome® for treatment of invasive aspergillosis Ended
  2024-513030-38-00 5 2022-02-15 Invasive fungal infections due to Aspergillus spp.
• A Research Study, where the participant and healthcare providers are aware of the treatment being given, to evaluate safety and effectivenes … Ended
  2022-501243-33-00 4 2022-02-03 Diffuse Large B Cell Lymphoma (a type of non-Hodgkin’s lymphoma, in pa
• Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J … Ended
  2023-505457-40-00 5 2022-02-02 Previously Untreated Advanced Gastric or Gastroesophageal Junction Can
• Neoadjuvant Nivolumab and chemotherapy in stage I-II triple negative breast cancer. Ended
  2024-512625-86-00 4 2022-01-27 Early stage triple negative breast cancer
• Study to evaluate Pegcetacoplan in patients with TA-TMA after hematopoietic stem cell transplantation Ended
  2023-510443-37-00 4 2022-01-26 Transplant-associated Thrombotic Microangiopathy (TA TMA)
• A Study of Evorpacept (ALX148) in Patients with Advanced Gastric Cancer Ended
  2023-509406-30-00 10 2022-01-24 Patients with HER2-overexpressing advanced or metastatic gastric or ga

Showing 2,161–2,184 of 2,391 trials